Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP

. OCMSET/6201/006 January 30, 2019 Re: The Disposition of Assets Relating to the Business of Manufacturing Accessories and Faucet Products which the Board of Directors’ Meeting No. 9/2018 Has Approved to

started resulting the Company has to realize the cost including the depreciation of factory, machinery and other system; however, the manufacturing capacity has not utilize in its full capacity and the

receivables as of 31 March 2019 were Baht 10,849 million, decrease of Baht 709 million or 6.7% down from its balance as of 31 December 2018. Most of the outstanding balance of trade and other receivables

receivables as of 30 June 2019 were Baht 11,480 million, a decrease of Baht 78 million or 0.7% down from the balance as of 31 December 2018. Most of the outstanding balance of trade and other receivables

summarized below. Net trade and other receivables as of September 30, 2019 were Baht 11,303 million, decrease of Baht 255 million or 2.2% down from its balance as of December 31, 2018. Most of the outstanding

Sep 2020 were Baht 14,195 million, increase of Baht 4,456 million or 45.8% from those of 31 December 2019. Reflected from the increasing in Sales Revenue, Most of the outstanding balance of trade and

1,423 million baht or 14.6% up from its balance as of 31 December 2019. Most of the outstanding balance of trade and other receivables, about 77% of total net trade and other receivables, were under

Baht 76 and gross profit margin for the second quarter of 2019 was decreased from 20% to 14%. It was due to the increase in cost of sales, which was the result of manufacturing expenses, which were

addition, the economic impact of Covid-19 will be only fully visible in the Q2-Q4 period of the year. However, as our business is essential to many manufacturing processes, and as we are quite diversified